Furthermore, as p53 mutations have previously been reported in 44%20 to 90%21 of vulvar cancers, we also evaluated effects of the CHK1 targeting in p53 mutant vulvar cancer cell lines in vitro. Here, TP53 is linked to vulva cancer.